Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -7.77M | $ -7.96 | 1 | 975.99K |
3/31/2025 | $ -7.02M | $ -6.4 | 1 | 1.1M |
12/31/2024 | $ -7.29M | $ -10.32 | 1 | 706.55K |
9/30/2024 | $ -6.65M | $ -10.72 | 1 | 620.13K |
6/30/2024 | $ -7M | $ -18.36 | 1 | 381.05K |
3/31/2024 | $ -6.66M | $ -13.85 | 1 | 480.65K |
12/31/2023 | $ -6.51M | $ -16.32 | 1 | 398.67K |
9/30/2023 | $ -7.36M | $ -44.25 | 1 | 166.41K |
6/30/2023 | $ -7.45M | $ -60.81 | 1 | 122.42K |
3/31/2023 | $ -10.8M | $ -64.9 | 1 | 166.41K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for INMED PHARMACEUTICALS INC is calculated as follows: FCF [ $ 0 ] / (Shares WA [ 10.44K ] * Share Factor [ 1 ])
(=) FCFPS [ $ 0 ]
Minimum
Jun 30, 2021
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.91 |
average | $ 0.81 |
median | $ 0.3 |
std | $ 2.83 |